Synjardy (empagliflozin and metformin hydrochloride)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) July 2016 BOX WARNING (revised as below) WARNING: LACTIC ACIDOSIS Postmarketing cases of metformin-associated lactic acidosis...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts